title: Focal Segmental Glomerulosclerosis Recurrence: Soluble Urokinase Receptor Left Out?
authors.affiliation: 1 Université Paris Descartes, Rue de l'Ecole de Médecine, Paris, France. 2 Service de Néphrologie et Transplantation, Hôpital Necker, Paris, France. 3 Institut National de la Recherche U1151, Hôpital Necker, Paris, France. 4 Paris Translational Research Center for Organ Transplantation and Cardiovascular Disease, Paris, France.
authors.forename: Guillaume
authors.initials: G
authors.lastname: Canaud
authors.forename: Alexandre
authors.initials: A
authors.lastname: Loupy
mesh_terms: D005260:Female; D005923:Glomerulosclerosis, Focal Segmental / Q000628:therapy*; D006801:Humans; D039661:Integrin beta3 / Q000378:metabolism*; D008297:Male; D008991:Monitoring, Physiologic / Q000379:methods*; D010951:Plasma Exchange / Q000379:methods*; D050199:Podocytes / Q000378:metabolism*; D055293:Receptors, Urokinase Plasminogen Activator / Q000378:metabolism*
chemical_list: D039661:Integrin beta3; D055293:Receptors, Urokinase Plasminogen Activator